Lidocaine Recall: Eugia US HCl Injection 2% 40 mg/2 mL
Announced 2026-06-10 · FDA
FDA recalls Lot 3LC26029A (exp Feb 2029) and Lot 3LC26031A (exp Mar 2029) of Lidocaine HCl Injection, USP 2%, 40 mg/2 mL, Rx Only, manufactured in India for Eugia US. The recall is due to a labeling issue where the barcode wrap covers the barcode making it hard to scan. The product was distributed nationwide in the US and about 168,300 vials may be affected.
| Brand | Eugia US LLC |
|---|---|
| Product | Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02 |
| Reason | Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan |
| Severity | low |
| Units affected | 168300 |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029 |
WHAT YOU SHOULD DO
- Check the lot numbers on your product and do not use any that match the recalled lots.
- Return or arrange disposal of the affected vials through the supplier or healthcare provider; request a replacement if available.
- Contact your pharmacist or healthcare professional with questions and monitor recall updates from the FDA.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.